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ABSTRACT Several regions within the 35-kDa COOH-terminal portion of caldesmon have been implicated in the ability of
caldesmon to inhibit actin-activated myosin ATPase activity. To further define the functional regions of caldesmon, we have
studied the effects of three chymotryptic fragments, one fragment produced by CNBr digestion and two fragments produced
by digestion with submaxillaris arginase C protease, on the relaxed stiffness and active force of rabbit psoas fibers. Each of
the regions of caldesmon studied had either direct or indirect effects on single-fiber mechanics. The 35-kDa and 20-kDa
fragments of caldesmon, like intact caldesmon, were effective inhibitors of fiber stiffness, a measure of cross-bridge
attachment. The 7.3-kDa and 1 0-kDa fragments, which constitute the NH2 and COOH halves of the 20-kDa fragment,
inhibited both relaxed fiber stiffness and active force production, but with a reduced efficacy compared to the 20-kDa
fragment. These results suggest that several regions within the 35-kDa COOH-terminal region of caldesmon are required for
optimum function of caldesmon and that function includes inhibition of weak cross-bridge attachment and force production.
INTRODUCTION
The primary switch for contraction of smooth muscle is
phosphorylation of the regulatory light chains of smooth-
muscle myosin (Itoh et al., 1989). However, there are indi-
cations that an actin-based system also participates in the
regulation of smooth-muscle contraction (Marston and
Smith, 1984; Marston and Lehman, 1985). Caldesmon, a
protein that is expressed in smooth-muscle and in non-
muscle tissues, has been proposed to be a component of this
additional regulatory system. By binding to actin, caldes-
mon inhibits actomyosin ATPase activity in solution (Cha-
lovich et al., 1987), the motility of actin filaments (Haeberle
et al., 1992), and both ATPase activity and force develop-
ment in single skinned skeletal-muscle (Brenner et al.,
1991) and smooth-muscle (Pfitzer et al., 1993) fibers.
Caldesmon is a multifunctional protein with binding sites
for both myosin and actin. The NH2-terminal region of
caldesmon binds to myosin (Velaz et al., 1990) and is
instrumental in cross-linking myosin to actin in vitro (Hem-
ric and Chalovich, 1988, 1990; Ikebe and Reardon, 1988).
There are many possible functions for this interaction, but at
present, the physiological role of this interaction has not
been determined. The central region of caldesmon is highly
a-helical (Wang et al., 1991a) and is flexible enough in
parts to allow the caldesmon to bend, so that the NH2 and
COOH regions may come into close contact (Martin et al.,
1991; Moody et al., 1990; Mabuchi et al., 1993; Crosbie et
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al., 1995). The COOH-terminal region, residues 450-756,
binds to actin and inhibits the actin-activated ATPase ac-
tivity of myosin (Szpacenko and Dabrowska, 1986; Fujii et
al., 1987; Yazawa et al., 1987; Riseman et al., 1989). This
COOH 35-kDa region is thought to contain the entire in-
hibitory region of caldesmon. Several groups have further
dissected the COOH-terminal region of caldesmon to iden-
tify its key functional regions. Several fragments have re-
ceived particular attention because of reports that they are
central to the inhibitory activity. A 10-kDa fragment pre-
pared by CNBr digestion of caldesmon (See Fig. 1) has been
reported to bind to actin with a stoichiometry of one frag-
ment per seven actin monomers, similar to that of intact
caldesmon (Bartegi et al., 1990). This fragment inhibits
actin-activated ATPase activity of S1, and this activity is
augmented by tropomyosin and attenuated by Ca2+-cal-
modulin. A similar fragment, 685C, was reported to maxi-
mally inhibit ATPase activity when one fragment was
bound per 14 actin monomers (Redwood and Marston,
1993). Based on these observations, the 10-kDa fragment
was thought to contain most of the regulatory function of
intact caldesmon. A 7.3-kDa fragment from the region of
caldesmon adjacent to the 10-kDa fragment bound to actin
with a 1:1 stoichiometry, but with low affinity (Chalovich et
al., 1992). This 7.3-kDa fragment was capable of reducing
the actin activation of Sl ATPase activity to low levels.
Like that of intact caldesmon, the inhibitory activity was
augmented by smooth-muscle tropomyosin and was re-
versed by Ca2+-calmodulin. The 7.3-kDa fragment over-
lapped the 10-kDa fragment by seven residues, and these
were suggested to be key residues in the function of caldes-
mon (Chalovich et al., 1992). Zhan et al. (1991) observed
that a synthetic peptide analog of the overlap region
(Gly651-Ser667) did bind to actin.
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FIGURE 1 Caldesmon fragments used in this study. The top panel
shows the relative position of the various fragments in the caldesmon
molecule, using the primary structure derived from Bryan et al. (1989) as
a reference. The bottom panel shows an SDS gel of the major caldesmon
fragments used. The fragments are (a) a 90-kDa submaxillaris arginase-C
protease fragment, (b) a 35-kDa chymotryptic fragment, (c) a 15-kDa
submaxillaris arginase-C protease fragment, (d) a 20-kDa chymotryptic
fragment, (e) a 10-kDa CNBr fragment, and (f) a 7.3-kDa chymotryptic
fragment.
Other observations, however, indicate that multiple re-
gions of the 35-kDa region are important in regulation. For
example, the stoichiometry of binding to actin decreases
with truncation of caldesmon (Chalovich et al., 1992). This
indicates that multiple regions of caldesmon are involved in
inhibition (see Redwood and Marston, 1993, for another
opinion). In addition, the competition of binding of caldes-
mon and S1 for actin is consistent with a model in which
there is a mosaic of binding sites involving multiple regions
of caldesmon interacting with different actin monomers
(Chen and Chalovich, 1992).
Because of the conflicting evidence for either the entire
35-kDa region or a small part of it having control of ATPase
activity and for differences among laboratories in the re-
ported properties of individual regions, we have reexamined
the question in a different manner. Several relevant
polypeptide regions derived from the 35-kDa region of
caldesmon have been compared; these are shown in Fig. 1.
The effect of the polypeptides on the mechanics of single
fibers was studied. In this way, the function of the fragments
could be compared in a highly organized muscle system,
and those parameters could be followed that are likely to be
important in the regulation of smooth-muscle contraction.
Psoas fibers rather than smooth-muscle fiber bundles were
used because they lack caldesmon, and the effect of adding
caldesmon can be readily seen (Brenner et al., 1991; Kraft
C et al., 1995a). Skeletal-muscle fibers do contain troponin,
which appears to be absent in smooth muscle. However, the
presence of troponin has only a minor effect, making the
-
5 binding of caldesmon to actin slightly stronger in the pres-
Phe 578 ence of calcium (Brenner et al., 1991).
ME[::::=Our results show that multiple fragments in the COOH-
Lys 579 Pro 756 terminal region of caldesmon inhibit force. Some individual
Trp 659 Pro 756 fragments have little effect on the fiber mechanics, although
597--Ph - 665 they clearly increase the activity of the intact molecule. Allu 7 fragments that inhibit force do so largely by inhibiting weak
cross-bridge attachment in the skeletal-muscle model. Fi-
nally, there is little difference in the behavior of the 7.3-kDa
and 10-kDa fragments that comprise the 20-kDa region. It is
likely that the 7.3-kDa and 10-kDa fragments are equally
important in the inhibitory function of caldesmon.
MATERIALS AND METHODS
Fiber preparation
Single chemically skinned fibers from rabbit psoas muscle were isolated
according to a method described earlier (Brenner, 1983; Yu and Brenner,
1989). The skinning solution always contained several protease inhibitors,
to prevent degradation of contractile proteins (see Solutions and Kraft et
al., 1995a). To provide conditions similar to those in vivo, we replaced
propionate by creatine-phosphate as the main anion to adjust the ionic
strength. Furthermore, to minimize oxidation of reactive groups within the
proteins, we added glutathione (10 mM) to the skinning solution. We also
isolated single fibers within a few hours after dissecting the muscle and
kept them as isolated fibers to reduce substrate depletion and diffusion
problems. These precautions resulted in even better preservation of the
mechanical stability of the muscle fibers than we had previously achieved
(Brenner, 1983).
Solutions
All solutions were adjusted to pH 7.0 at the appropriate temperature. The
chemicals were obtained from Sigma Chemie (Munich, Germany), except
where noted. The skinning solution was (,u = 170 mM): 5 mM KH2PO4,
3 mM magnesium-acetate, 5 mM EGTA, 1 mM sodium-ATP (Merck), 50
mM sodium creatine phosphate, 5 mM NaN3, 10 mM glutathione, 1 mM
phenylmethylsulfonyl fluoride, and 10 ,uM each of aprotinin, leupeptin,
antipain, E64, and pepstatin A. Glutathione and the protease inhibitors
were freshly added before the solution was used. Immediately after dis-
section, the fiber bundles were incubated for 30 min at 50C in skinning
solution containing 0.5% Triton-X-100. The bundles were then transferred
to normal skinning solution for isolation of single fibers. The relaxing
solution with MgATP was (,u = 50 mM): 10 mM imidazole, 2mM MgCl2,
1 mM EGTA, 1 mM sodium-ATP (Merck), 1 mM dithiothreitol, and 10
mM sodium creatine phosphate. The low-salt relaxing buffer (,u = 50 mM)
was: 10 mM imidazole, 2 mM MgCl2, 1 mM EGTA, 1 mM dithiothreitol,
and 35 mM potassium propionate. The preactivating and activating solu-
tions were (,u = 50 mM): 10mM imidazole, 2 mM MgCl2, 1 mM MgATP,
1 mM dithiothreitol, 10 mM caffeine, 10 mM creatine phosphate, 500
units/ml (Sigma units) of creatine phosphokinase and 1 mM EGTA (pre-
activating) or 1 mM CaEGTA (activating). The MgPPi solution was (,t =
170 mM): 10mM imidazole, 2mM MgCl2, 1 mM CaEGTA, 4 mM MgPPi,
1 mM dithiothreitol, and 140 mM potassium propionate.
Mechanical apparatus
The mechanical setup, including the system for laser light diffraction to
record sarcomere length, was previously described (Brenner, 1980; Bren-
ner and Eisenberg, 1986).
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Fiber stiffness and isometric tension
Fiber stiffness was measured during rapid ramp-shaped stretches that were
imposed on one end of the fiber. Fiber stiffness was defined as the force
change when filament sliding has reached 2 nm per half-sarcomere (chord
stiffness). The maximum isometric tension was determined as the drop in
force upon changeover to unloaded shortening.
Analysis of stiffness data
Fitting a hyperbolic function to the concentration dependence of the
stiffness data enabled us to estimate the maximum inhibition of cross-
bridge binding. The association constant of caldesmon binding to actin in
the fiber, KAfiber, was estimated from the reciprocal of the concentration of
caldesmon giving half-maximum inhibition. Because the volume of the
bath surrounding the fiber was much larger than the fiber volume (>100:
1), we assumed that the free fragment concentration was equal to the total
concentration added.
Removal of caldesmon and caldesmon fragments
from the fibers
To ensure reversibility of effects on fiber mechanics, caldesmon and
caldesmon fragments were removed at the end of each experiment. These
proteins were removed by incubation of the fibers in a MgPPi solution with
calcium (pCa = 4.5) containing calmodulin (0.1 mg/ml) for the same
length of time that was needed initially to achieve an equilibrium concen-
tration of that fragment in the fiber. Usually 90-110% of the initial fiber
stiffness and force were restored.
Proteins
Actin (Eisenberg and Kielley, 1972; Spudich and Watt, 1971), tropomyo-
sin-troponin (Eisenberg and Kielley, 1974), and myosin (Kielley and
Harrington, 1960) were prepared from rabbit skeletal muscle. Myosin SI
was prepared as described by Weeds and Taylor (1975). Caldesmon was
prepared from turkey gizzards by a modified method of Lynch et al.
(1987).
Several caldesmon fragments were used in this study; these are defined
in Fig. 1. The 7.3-kDa, 20-kDa, and 35-kDa fragments were obtained by
digestion of caldesmon with chymotrypsin under conditions similar to
those used by Szpacenko and Dabrowska (1986): 5 min at 25°C with
1:1000 (w/w) ratio of chymotrypsin to caldesmon. The caldesmon was at
5-10 mg/ml in 100 mM NaCl, 10 mM Tris-2-[N-morpholino]ethanesulfo-
nic acid (Tris-MES) (pH 7.0), and 2 mM dithiothreitol. The 7.3-kDa and
20-kDa fragments were isolated as described earlier (Chalovich et al.,
1992; Velaz et al., 1993). The 35-kDa fragment was isolated using a
high-performance liquid chromatography cation exchange column (SP R,
Waters) (see figure 1 of Chalovich et al., 1992). Low-molecular-weight
components were removed by gel filtration on a 1.5 X 95 cm column of
ACA 54 (Spectrum, Los Angeles) equilibrated with 0.5 M KCl, 10 mM
imidazole (pH 7.0), and 1 mM EDTA. The first peak contained the 35-kDa
fragment.
The 15-kDa and 90-kDa fragments were prepared by a slight modifi-
cation of the method of Mornet et al. (1988). Caldesmon was diluted to 2
mg/ml with 50 mM Tris-HCl (pH 8.0), 0.5 mM dithiothreitol, and 1 mM
EGTA and digested with a 1/500 molar ratio of submaxillaris arginase-C-
protease at 37°C for 90 min. The digestion was stopped by the addition of
phenyl methyl sulfonyl fluoride, and the mixture was applied to a 1.5 x
100 cm column of ACA 54 equilibrated as above. The first broad peak
contained a crude 90-kDa fragment, and the second broad peak contained
a crude 15-kDa fragment. The crude 90-kDa and 15-kDa fragments were
individually purified by chromatography on a HPLC SP R (Waters) cation
exchange column equilibrated with 10 mM Tris-MES, pH 7.0, 60 mM
NaCl, 1mM NaN3, and eluted with a gradient of NaCl to 1 M.
The 10-kDa fragment was prepared by digestion with CNBr. Caldes-
mon at 10 mg/ml was mixed with 88% formic acid and CNBr to give 2.5
mg/ml caldesmon, 70% formic acid, and 20 mg/ml CNBr and incubated at
room temperature for 24 h. After two cycles of dilution and lyophilization,
the pellet was dissolved in 1 M KCl and chromatographed using ACA 54
gel filtration media as described for the 7.3-kDa fragment. The second
broad peak contained the 10-kDa fragment. Final purification was done on
the SP column as described earlier. The pure 10-kDa fragment was recov-
ered in the sharp second peak.
Binding studies
In those cases in which fragments were without effect on fiber mechanics,
the binding of the fragments to actin was estimated by using a cosedimen-
tation assay. A 30-min incubation of 5 ,vM filamentous actin with 2 ,tM
fragment in low-salt relaxing buffer at 25°C was followed by sedimenta-
tion at 160,000 x g for 25 min in a 50-Ti rotor. The sediment was
dissolved in low-salt relaxing buffer and loaded onto a polyacrylamide gel
in the presence of sodium dodecyl sulfate (Laemmli, 1970), together with
four known amounts of fragment. After staining with Coomassie blue or
silver stain, the amount of bound fragment could be determined by video
densitometry. Before estimating the binding constant, KASOIUtIof, the data
were corrected for the amount of fragment that was present in the sediment
in the absence of actin.
ATPase assays
The ATPase activity of S1 was measured at 25°C by the liberation of 32Pi
from [32P]ATP as described by Chalovich and Eisenberg (1982). Low-
ionic-strength conditions were used in the ATPase assays to promote the
interaction of S1 with actin and increase the sensitivity of measurement of
inhibitory potential of the caldesmon fragments. The reaction mixture
included 10 ,uM actin, 0.1 .tkM S1, 10 mM imidazole (pH 7.0), 1 mM
MgATP, 1 mM MgCl2, 17 mM potassium propionate, 1 mM dithiothreitol,
and either 1 mM EGTA or 0.5 mM CaEGTA.
RESULTS
To study the effect of caldesmon fragments on fiber me-
chanics, it is critical that the polypeptides be uniformly
distributed throughout the fiber. Fig. 2 shows the time
course of diffusion of some of the fragments into the fibers,
monitored by the effect on fiber stiffness. The rate of
diffusion varied with the size and shape of the fragment and
is likely to involve affinity of the fragment for actin and
other muscle components. The rate of diffusion followed the
order 7.3-kDa > 10-kDa (not shown) ' 20-kDa > 35-kDa
fragment > intact caldesmon. In all subsequent experi-
ments, incubation with fragments was continued for the
time that ensured a maximum effect.
The measured inhibition of cross-bridge binding to actin
required not only diffusion, but also docking of the caldes-
mon fragments in the correct orientation relative to the actin
filaments. The rate of equilibration measured earlier with a
confocal microscope and fluorescently labeled 35-kDa frag-
ment was similar to that shown here (Kraft et al., 1995b).
Because there is good correlation between the visually and
mechanically measured time courses, we conclude that dif-
fusion is the limiting process, whereas reorientation occurs
comparatively quickly.
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FIGURE 2 Time courses of diffusion into a single fiber for caldesmon
(@) and fragments with molecular masses of 7.3 kDa (0), 20 kDa (A), and
35 kDa (U). The figure shows data of representative experiments with
different fibers. The fibers were incubated with fragment concentrations
close to l/KAfiber. The curves shown are normalized to the maximum
change in stiffness observed in each case.
To achieve a standard to compare the inhibition caused
by caldesmon fragments, we first tested the inhibitory effect
of the intact molecule in the fiber (Fig. 3, filled circles).
From fitting a hyperbolic curve to the data, we obtained an
apparent association constant for the binding of caldesmon
to native skeletal thin filaments of 3 X 106 M-1. The
maximum inhibition of cross-bridge binding to the thin
filament was extrapolated to about 87%. This compares to
approximately 95% inhibition of ATPase activity in solu-
tion. Table 1 contains a summary of the properties of
caldesmon and its fragments. The estimate of the affinity of
caldesmon for actin in fibers is in good agreement with
values obtained by direct binding measurements in solution.
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FIGURE 3 Effects of intact caldesmon (-, n = 15), the 90-kDa frag-
ment (0, n = 4), and the 35-kDa fragment (U, n = 16) on fiber stiffness
under relaxing conditions. All data were normalized to the value of the
fiber stiffness before caldesmon or the fragment was added to the solution.
The dotted line marks 100%.
I -
the 15-kDa fragment has no activity.
The N-terminal 90-kDa fragment of caldesmon lacks the
COOH-terminal actin binding/inhibitory domain. Fig. 4
shows that this fragment did not inhibit the actin-activated
ATPase activity of skeletal myosin SI at low ionic strength.
In some cases there was even a small activation (20%) of
the ATPase activity. Such an activation would occur if the
fragment bound weakly to actin in addition to binding to
myosin, thereby increasing the effective concentration of
these proteins. The inset to Fig. 4 shows results of cosedi-
mentation of the 90-kDa fragment with actin. The upper
limit for the affinity of this fragment is about 7 X 103 M-1
or 1/500 that of intact caldesmon. Fig. 3 (open circles)
shows that this fragment had no significant effect on relaxed
fiber stiffness, although this lack of effect could be due to
inadequate binding of the 90-kDa fragment.
The 35-kDa fragment contains the C-terminal region of
caldesmon and together with the 90-kDa fragment would
constitute the entire caldesmon molecule. This fragment
was an effective inhibitor of cross-bridge attachment for the
concentrations used in our study (Fig. 3, solid squares) and
had an effect similar to that of intact caldesmon. From the
dependence of the inhibition of cross-bridge attachment on
the 35-kDa fragment concentration, we have estimated the
apparent association constant to actin filaments in fibers to
be 7 x 106 M-1. Whereas the apparent affinity was slightly
greater than that of intact caldesmon, the maximum inhibi-
tion, about 70%, was less than that of intact caldesmon. By
comparing the fragments shown in Fig. 3, the 90-kDa frag-
ment contributes little to the potency of inhibition by caldes-
mon. However, from inspection of Table 1, it appears that
the 90-kDa fragment is able to extend the inhibitory effect
of caldesmon from four actin monomers to seven.
The 35-kDa fragment may be further dissected to deter-
mine which regions are essential for the inhibition of cross-
bridge attachment in fibers. The 15-kDa fragment shows
sequence homology with troponin T (Bryan et al., 1989) and
is reported to contain a weak actin-binding site (Mornet et
al., 1988). This fragment had no effect on actin-activated
ATPase activity at fragment concentrations up to 20 ,uM,
and a cosedimentation assay indicated that the binding to
actin was very weak, KAfiber < 2 X 103 M-1 (data not
shown). Fig. 5 (open squares) shows that the 15-kDa frag-
ment has no apparent effect on relaxed fiber stiffness.
Therefore this fragment contains little information, by itself,
for binding to actin. In contrast, the other part of the 35-kDa
region, a fragment with a molecular mass of 20 kDa (Fig. 5,
filled triangles), again inhibited cross-bridge binding to
actin by 70%, but the apparent affinity was decreased to 1 X
106 M- 1 in the fiber. This fragment has already been shown
to bind to actin and calmodulin, in solution, and to inhibit
ATPase activity and the attachment of S1 to actin (Velaz et
al., 1993). Although the 20-kDa fragment is a potent inhib-
itor, it is not as effective in binding or inhibition as the
35-kDa fragment. Thus, at least part of the 15-kDa fragment
is important in the function of caldesmon, although by itself
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TABLE 1 Effect of caldesmon fragments on fiber mechanics
Kasolution Kafiber [fragment] for % Inhibition % Inhibition
Species n*# (M- #§ (M-)¶ 50% inhibitionl of stiffness of force
Caldesmon 7 or (5 and 22) 107 3 x 106 0.8 ,uM 87 90**
90 kDa <7X 103 - ND## -0
35kDa 4 3.5x106 7X106 70
15 kDa <2X 103
-0
20 kDa 2 6 x 105 1 X 106 70 85**
7.3 kDa 1 5 X 104 8 X 104 10 ,uM -48 >25
10 kDa 7 4 X 103 <8 x 104 >30p.M >30 >45
*n is the number of actin monomers in a single site.
#References: caldesmon, Velaz et al. (1993) and Smith et al. (1987); 35 kDa, Yazawa et al. (1987); 20 kDa, Velaz et al. (1990); 7.3 kDa, Chalovich et al.
(1992); 10 kDa, Bartegi et al. (1990). The 90-kDa and 15-kDa values are from the present work.
§Affinity in solution determined by direct binding assays.
'Estimate of affinity in fibers determined by inhibition of stiffness.
I1The concentration of caldesmon or fragment required to obtain 50% inhibition of ATPase activity in the absence of tropomyosin under the conditions of
Fig. 4.
**Brenner et al. (1991).
##ND, No inhibition detected.
The 20-kDa region can be further cleaved to more nar-
rowly define the essential portions of caldesmon. Digestion
of the 20-kDa fragment with chymotrypsin yields a 7.3-kDa
fragment that is essentially the amino-terminal half of the
20-kDa fragment. This fragment was shown earlier to in-
hibit the actin-activated ATPase activity by more than 80%
(Chalovich et al., 1992). This fragment also inhibited fiber
1.2 ° O
0
0 03
- 0.8-
A B C D E F G
90 kDa-
0.4 fragment
0
z
Actin -
0.0
0 2 4 6 8 10
[90 kDa Fragment], ,uM
FIGURE 4 Effect of the 90-kDa caldesmon fragment on actin activated
ATPase activity and the binding of the 90-kDa fragment to actin (inset).
The ATPase rates were measured with two preparations of the fragments
(0, °) at the following conditions: 25°C, 10 tsM actin, 0.1 ,uM S1, 10 mM
imidazole, pH 7.0, 1 mM MgATP, 1 mM MgCl2, 17 mM potassium
propionate, 1 mM dithiothreitol, and either 1 mM EGTA or 0.5 mM CaCl2
and 0.5 mM EGTA. (Inset) The pellets of protein mixtures after high-speed
centrifugation were run on SDS-polyacrylamide gels (5-15% gradient).
Lanes: A, actin; B, 90-kDa fragment; C, actin and the 90-kDa fragment.
Lanes D-F contain known amounts of 90-kDa fragments: D, 0.25 ,ug; E,
0.5 Kg; F, 1 jsg.
stiffness (Fig. 5, diamonds). The data were fitted to a
binding constant of 8 X 104 M-1, with a maximum inhibi-
tion of 48%.
It was surprising that the 7.3-kDa fragment was more
effective in inhibiting ATPase activity in solution than force
and stiffness in the fiber. ATPase assays were done to
determine if the troponin-tropomyosin present in the psoas
fibers limited the activity of the 7.3-kDa fragment. Fig. 6
shows that this was not the case. The 7.3-kDa fragment
inhibited the actin activated the ATPase rate of SI, both in
the absence of troponin-tropomyosin and in the presence of
troponin-tropomyosin and Ca2 . In both cases, the total
inhibition of ATPase activity exceeded 90%. Therefore, the
reduced efficacy of the 7.3-kDa fragment in fibers cannot be
attributed to the presence of troponin.
The 10-kDa actin-binding fragment resulting from a
CNBr digest of caldesmon most likely includes amino acid
residues 659-756 and is the COOH-terminal half of the
20-kDa fragment (Bartegi et al., 1990). The 10-kDa frag-
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FIGURE 5 Effects of 20-kDa (A, n = 10), 15-kDa (O, n = 4), and
7.3-kDa (O, n = 4) and 10-kDa CNBr (A, n = 3) fragments on fiber
stiffness under relaxing conditions.
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FIGURE 6 Inhibition of actin-activated ATPase activity of SI by the
7.3- and 10-kDa caldesmon fragments. (A) The 7.3-kDa fragment in the
absence ( O ) and presence ( * ) of skeletal muscle troponin-tropomyosin.
(B) The 10-kDa caldesmon fragment in the absence (A) and presence (A)
of smooth-muscle tropomyosin. The conditions were the same as in Fig. 4.
ment inhibited ATPase activity, as shown in Fig. 6 B. As
with intact caldesmon, the inhibition was greater in the
presence of smooth-muscle tropomyosin. In the absence of
tropomyosin the 10-kDa fragment is not as good an inhib-
itor as the 7.3-kDa fragment; concentrations of the 10-kDa
fragment approximately three times higher relative to the
7.3-kDa fragment were required to provide 50% inhibition
of ATPase activity. The 10-kDa fragment also inhibited the
actin-activated ATPase activity in the presence of troponin-
tropomyosin by 60-80% (not shown) and could therefore
be studied in single fibers.
Fig. 5 (open triangles) shows that the 10-kDa CNBr
fragment did inhibit fiber stiffness. However, higher con-
centrations of the 10-kDa fragment relative to the 7.3-kDa
fragment were required to give the same degree of inhibi-
tion. Fig. 7 shows that in addition to inhibiting stiffness,
both the 10-kDa and 7.3-kDa fragments inhibited the active
force produced by single fibers upon activation. Therefore,
like the inhibition by intact caldesmon (Brenner et al., 1991)
and the 20-kDa fragment (Kraft et al., 1995a), the inhibition
of stiffness by the 10-kDa and 7.3-kDa fragments is accom-
panied by an inhibition of active force.
DISCUSSION
The present results indicate that many regions within the
35-kDa COOH-terminal fragment of caldesmon are instru-
100
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FIGURE 7 Inhibition of force and stiffness caused by 65 ,uM of either
the 7.3-kDa fragment (n = 4) or the 10-kDa fragment (n = 4). ATP,yS (an ATP analog that does not support contraction)
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mental in the inhibition of actin-activated ATPase activity
of myosin. The individual regions can be divided into two
types, depending on whether they exhibit a direct or indirect
effect on ATPase activity. Most of the fragments investi-
gated have a direct effect on the ATPase activity and, as
shown in the present work, inhibit force production in
muscle. Both the 7.3-kDa and 10-kDa fragments, which
comprise the 20-kDa region, have this direct inhibitory
activity. These fragments do share a common seven amino
acid region, but it is unlikely that this region alone is
responsible for the inhibitory activity of both fragments,
because the 20-kDa region is much more active than either
of these fragments, yet it contains only a single copy of the
seven amino acid overlap region. Our results do not support
the idea that either the 7.3-kDa or 10-kDa fragment can
reproduce all of the functions of caldesmon.
We have suggested earlier that a major component of the
inhibition by caldesmon is due to a reduction in the occu-
pancy of actin-binding sites by myosin-ATP complexes
(Chalovich et al., 1987; Hemric and Chalovich, 1988; Velaz
et al., 1990). Our own earlier work with troponin-tropomy-
osin indicated that the major effect with this regulatory
system was to inhibit the kinetics, presumably the rate of
transition from the nonactivating (weak binding) to the
activating (strong binding) states (Chalovich et al., 1982;
Brenner et al., 1982; Brenner, 1988). The mechanical ex-
periments described here and earlier (Brenner et al., 1991;
Kraft et al., 1995a) show that caldesmon functions by in-
hibiting the attachment of weakly binding cross-bridges to
actin. Our earlier studies showed that caldesmon has no
significant effect on the cycling kinetics in the skeletal
muscle model. Most importantly, those results demonstrated
that inhibition of attachment of nonactivating cross-bridges
(i.e., myosin-ATP or myosin-ADP-P1) by caldesmon is by
itself capable of inhibiting active force. We have now ob-
served that each of the caldesmon fragments that was shown
to inhibit force production was shown to inhibit relaxed
fiber stiffness, i.e., the attachment of nonactivating cross-
bridges to actin. In the case of the 10-kDa fragment, the
force is inhibited to a slightly greater degree than is the
stiffness. This could be interpreted as the existence of a dual
mechanism of inhibition by this fragment; that is, inhibition
of both cross-bridge attachment and the subsequent conver-
sion to the activating state. Even in our hands, caldesmon
does have a small effect on the kcat of ATP hydrolysis
(Hemric et al., 1993). However, it is more likely that the
small disparity between the degree of inhibition of stiffness
and force results from the same effect seen earlier with the
20-kDa fragment (Brenner et al., 1991; Kraft et al., 1995a).
In that case, the greater inhibition of active force (in the
presence of Ca2+) than relaxed stiffness (in the absence of
Ca2+) was due to a small increase in the affinity of caldes-
mon for actin-tropomyosin-troponin in the presence of
Ca2+. The stiffness of fibers measured in the presence of
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and Ca2+ did decrease in close parallel to the active force
measured in the presence of ATP and Ca2+ (Kraft et al.,
1995a).
At least one region of caldesmon has an indirect role in
the inhibition of contraction. In agreement with Momet et
al. (1988) and Hayashi et al. (1991), we observed that the
15-kDa fragment bound only weakly to actin and was not
inhibitory, even at comparably high concentrations. Al-
though the maximum inhibition is similar for the 20-kDa
and 35-kDa fragments (Fig. 5), removal of the 15-kDa
region from the 35-kDa fragment, to form the 20-kDa
fragment, decreased the actin affinity to 14%, and reduced
the number of actin monomers bound per fragment from
three or four (Yazawa et al., 1987) to two (Velaz et al.,
1993). It is conceivable that despite the low actin affinity of
the isolated 15-kDa fragment, this region may bind to actin
and interfere with cross-bridge attachment when other parts
of caldesmon constrain it to a specific location on actin.
This is reasonable because NMR studies have implicated
residues within the 15-kDa region, as well as in the 20-kDa
region, in binding to actin (Momet et al., 1995).
The competition of binding between S1-AMP-PNP and
caldesmon for actin is not purely competitive, but is more
readily fit with a model containing a mosaic of binding sites
(Chen and Chalovich, 1992). That model assumed that some
actin monomers covered by caldesmon were totally ex-
cluded from S1 binding, whereas others were partially ex-
cluded; a component of regulation through an allosteric
effect is also possible in this model. The finding that two
small fragments within the 35-kDa inhibitory region, the
7.3-kDa and 10-kDa fragments, inhibit both force and stiff-
ness, whereas the 15-kDa fragment has little effect by itself
on either parameter, is consistent with that model. In addi-
tion, although caldesmon does not have a repetitive binding
sequence for actin, a single caldesmon molecule interacts
with at least seven actin monomers. Thus it is likely that
different interactions are responsible for the association of
each caldesmon region.
An interesting aspect of the present work is that the 7.3-,
10-, 20-, and 35-kDa fragments gave >85% inhibition of
ATPase activity in solution, although higher concentrations
of the smaller fragments were required to reach this level of
inhibition. In the fiber the maximum level of inhibition
decreased substantially as the size of the fragment de-
creased. This difference between solution and fiber studies
cannot be attributed to the presence of troponin, because
troponin does not affect the maximum degree of inhibition
of ATPase activity by the fragments in solution. Among
many possible reasons for this difference is the presence of
other actin-binding proteins, such as nebulin, which may
partially restrict the binding of some of the caldesmon
fragments. This difference may provide clues to the function
of caldesmon, and it illustrates the importance of testing
regulatory proteins both in solution and in a more highly
organized system.
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